A high molecular weight drug is transdermally administered by applying a polymer skin enhancer and a drug active to the skin of the patient. The drug active has a molecular weight of above 50 daltons and takes at least 15% by weight of the system. The drug may be encapsulated or the drug solution may...http://www.google.es/patents/US6024975?utm_source=gb-gplus-sharePatente US6024975 - Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
Method of transdermally administering high molecular weight drugs with a ...
